Abstract: The embodiments of the present invention provide a panoramic sea view monitoring method, said method including: aligning any two adjacent monitoring cameras among a plurality of monitoring cameras, so that the any two adjacent monitoring cameras are located on the same physical horizontal plane in a field of view; obtaining monitoring images by using the plurality of aligned monitoring cameras and a depth-of-field camera to monitor a panoramic sea view; determining a horizontal spacing parameter and a vertical spacing parameter of the any two adjacent monitoring cameras; and using the horizontal spacing parameter and the vertical spacing parameter to combine the monitoring images in a pairwise manner, so as to construct a two-dimensional scene. The present invention also provides a panoramic sea view monitoring device, a server and a system. The present invention can reduce the complexity of the system while reducing the cost.

Abstract: A touch panel includes a driving layer and a sensing layer. The driving layer has a first top surface and a driving layer edge. The first top surface has at least one first connecting region. The driving layer edge surrounds the first connecting region and there is a first distance between the first connecting region and the driving layer edge. The sensing layer is disposed on the first top surface of the driving layer. The second top surface of sensing layer away from the driving layer has at least one second connecting region. The sensing layer edge of the sensing layer surrounds the second connecting region, and there is a second distance between the sensing layer edge and the at least one second connecting region.

Abstract: The present invention relates to novel Chromane-Substituted Tetracyclic Compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, A?, R2 R3, R4 and R5 are as defined herein. The present invention also relates to compositions comprising a Chromane-Substituted Tetracyclic Compound, and methods of using the Chromane-Substituted Tetracyclic Compounds for treating or preventing HCV infection in a patient.

Abstract: The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A?, R2 R3 and R5 are as defined herein. The present invention also relates to compositions comprising at least one Heterocycle-Substituted Tetra-cyclic Compound, and methods of using the Heterocycle-Substituted Tetracyclic Compounds for treating or preventing HCV infection in a patient.

Abstract: A lens structure including a quarter wave plate layer and a linear polarizing plate layer is provided. When the linear polarizing plate layer is located at an outer side of the lens away from a viewer's eye, the polarizing axis of the linear polarizing plate layer is in a vertical direction. The lens structure can be used to make dual-purpose eyeglasses with sunglasses and 3D glasses functions. Any one of the quarter wave plate layer and the linear polarizing plate layer can be disposed at the outer side away from the user's eyes by adjusting the orientation of the lens of the present invention. When the linear polarizing plate layer is located at the outer side away from the user's eyes, the optical axis of the linear polarizing plate layer is in the vertical direction. Thus, the dual-purpose eyeglasses with both sunglasses and 3D glasses functions can be achieved.

Abstract: Shellac is used as a thermal protectant to protect hair from damage by the heat generated from styling tools such as flat irons, curling irons, curling brushes, blow dryers and the like.

Abstract: A compound of Formula (I) or (II), for treating or preventing an HCV infection in a subject.

Abstract: The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

Abstract: The present invention is directed to compounds of Formula I pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS.

Abstract: The present disclosure provides a touch-sensing electrode structure, which includes a plurality of touch-sensing electrodes. Each of the touch-sensing electrodes includes a main body and a connecting portion connected to an end of the main body; wherein the width of the connecting portion is not less than a half width of the end of the main body. The touch-sensing electrode structure also includes a plurality of signal-transmitting wires, each of which includes a head portion and a tail wire connected to the head portion. The head portions of the signal-transmitting wires is superimposed on the connecting portions and electrically connected to the connecting portions respectively. Furthermore, a method of manufacturing the above touch-sensing electrode structure is also provided.

Abstract: The gloss of iced frozen baked goods once thawed, is enhanced by coating the baked goods with shellac prior to freezing.

Abstract: The gloss of iced frozen baked goods once thawed, is enhanced by coating the baked goods with shellac prior to freezing.

Abstract: The present invention is directed to piperazine derivatives, pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS.

Abstract: The present invention relates to novel Fused Tetracyclic Heterocyclic Compounds of Formula I: (I), wherein A, A?, R2A, R2B, R7, R8, R9, and R10 are defined herein. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HCV and the prophylaxis, treatment, or delay in the onset of disease caused by HCV. The present invention also relates to pharmaceutical compositions comprising at least one Fused Tetracyclic Heterocyclic Compound, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines, and methods of using the Fused Tetracyclic Heterocyclic Compounds for treating or preventing HCV infection in a patient.

Abstract: The present invention relates to novel Fused Tetracyclic Heterocyclic Compounds of Formula I: (I), wherein A, A?, R2A, R2B, R7, R8, R9, and R10 are defined herein. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HCV and the prophylaxis, treatment, or delay in the onset of disease caused by HCV. The present invention also relates to pharmaceutical compositions comprising at least one Fused Tetracyclic Heterocyclic Compound, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines, and methods of using the Fused Tetracyclic Heterocyclic Compounds for treating or preventing HCV infection in a patient.

Abstract: A touch panel includes a driving layer and a sensing layer. The driving layer has a first top surface and a driving layer edge. The first top surface has at least one first connecting region. The driving layer edge surrounds the first connecting region and there is a first distance between the first connecting region and the driving layer edge. The sensing layer is disposed on the first top surface of the driving layer. The second top surface of sensing layer away from the driving layer has at least one second connecting region. The sensing layer edge of the sensing layer surrounds the second connecting region, and there is a second distance between the sensing layer edge and the at least one second connecting region.

Abstract: The present invention is directed to compounds of Formula I pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS.

Abstract: A method of removing a dummy gate dielectric layer is provided. Firstly a first plasma containing F is utilized to remove the dummy dielectric layer which contains Si and O. Then a second plasma containing H2 is utilized to remove fluorine compound on the surface of the semiconductor substrate. Since the fluorine residue formed after the first plasma treatment reacts with the second plasma to form a gaseous product HF, the fluorine element can be taken away from the semiconductor device with the HF, which prevents inversion layer offset and gate current leakage occurred in the subsequent processing steps due to the fluorine element.

Abstract: A touch panel includes a driving layer and a sensing layer. The driving layer has a first top surface and a driving layer edge. The first top surface has at least one first connecting region. The driving layer edge surrounds the first connecting region and there is a first distance between the first connecting region and the driving layer edge. The sensing layer is disposed on the first top surface of the driving layer. The second top surface of sensing layer away from the driving layer has at least one second connecting region. The sensing layer edge of the sensing layer surrounds the second connecting region, and there is a second distance between the sensing layer edge and the at least one second connecting region.

Abstract: The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.